Theralase Technologies Inc. (TSXV:TLT)
Canada · Delayed Price · Currency is CAD 0.1800
-0.0050 (-2.70%)
Sep 22, 2026, 3:08 PM EST
Theralase Technologies Market Cap
Theralase Technologies has a market cap or net worth of CAD 55.89 million as of September 22, 2026. Its market cap has increased by 14.43% in one year.
Market Cap
55.89M
Enterprise Value
50.77M
Revenue
802.46K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.18
ChartMarket Cap Chart
Since April 2, 1996, Theralase Technologies's market cap has increased from 8.33M to 55.89M, an increase of 571.10%. That is a compound annual growth rate of 6.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 55.89M | 27.86% |
| Dec 31, 2025 | 43.71M | -33.43% |
| Dec 31, 2024 | 65.66M | 64.23% |
| Dec 28, 2023 | 39.98M | -42.29% |
| Dec 30, 2022 | 69.28M | -9.56% |
| Dec 31, 2021 | 76.60M | 97.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Profound Medical | 312.72M |
| Vector Science and Therapeutics | 295.53M |
| Cannabix Technologies | 47.91M |
| Perimeter Medical Imaging AI | 43.73M |
| Cheelcare | 34.09M |
| Conavi Medical | 21.39M |
| MedX Health | 18.04M |
| Ventripoint Diagnostics | 17.36M |